Alport syndrome and diffuse leiomyomatosis. Clinical aspects, pathology, molecular biology and extracellular matrix studies. A synthesis

Nephrologie

Volumn 21, Issue 1, 2000, Pages 9-12

  Garcia Torres, R ^b   Cruz, D ^b   Orozco, L ^b   Heidet, L ^a   Gubler, M C ^a  

^a INSERM   (France)

^b NONE

Author keywords

Alport syndrome; Expression of alpha IV chains; Leiomyomatosis; Molecular Biology; Oesophageal leiomyoma; X linked transmission

Indexed keywords

ACTIN; COLLAGEN TYPE 4; DESMIN; FIBRONECTIN; INTEGRIN; LAMININ;

ALPORT SYNDROME; CELL PROLIFERATION; CLINICAL FEATURE; DISEASE ASSOCIATION; ESOPHAGUS TUMOR; EXTRACELLULAR MATRIX; EYE MALFORMATION; GENE MUTATION; GENETIC DISORDER; GLOMERULUS BASEMENT MEMBRANE; HEARING IMPAIRMENT; HEMATURIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTRON; LEIOMYOMATOSIS; PROTEIN EXPRESSION; RETINA MACULOPATHY; REVIEW; SMOOTH MUSCLE FIBER; X CHROMOSOME DOMINANT INHERITANCE;

COLLAGEN; FEMALE; HUMANS; LEIOMYOMATOSIS; MALE; MUTATION; NEPHRITIS, HEREDITARY; X CHROMOSOME;

EID: 0034049609     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Garcia-Torres R, Guarner V. Leiomiomatosis del esófago, traqueobronquial y genital asociada con nefropatía hereditaria tipo Alport: Un nuevo síndrome. Rev Gastroenterol Mex 1983 ; 48 : 163-70.
2. Garcia-Torres R, Orozco L. Alport-Leiomyomatosis syndrome: An update. Am J Kidney Dis 1993 ; 22 : 641-8.
3. Antignac C, Heidet L. Mutations in Alport syndrome associated with diffuse esophageal leiomyomatosis. In Tryggvason K (ed): Molecular pathology and genetics of Alport syndrome. Contrib Nephrol Basel: Karger, 1996 ; 117 : 172-82.
4. Van Loo A, Vanholder R, Buytaert I, De Paepe A, Praet M, Elewaut A, Lameire N. Alport syndrome and diffuse leiomyomatosis with major morbid events presenting at adult age. Nephrol Dial Transplant 1997 ; 12 : 776-80.
5. Thorner P. Heidet L, Moreno Merlo F, Vern E, Antignac C, Gubler MC. Diffuse leiomyomatosis of the esophagus : Disorder of cell-matrix interaction? Pediatr Devel Pathol 1998 ; 1 : 543-9.
6. Dahan K, Heidet L, Zhou J, Mettler G, Leppig KA, Proesmans W, David A, Roussel B, Mongeau JG, Gould JMD, Grünfeld JP, Gubler MC, Antignac C. Smooth muscle tumors associated with X linked Alport syndrome: Carrier detection in females. Kidney Int 1995 ; 48: 1900-6.
7. Heidet L, Forestier L, Antignac C, Gubler MC. Syndrome d'Alport, une maladie héréditaire du collagéne de type IV. M/S 1997 ; 13 : 28-36.
8. Kleppel M, Kashtan CE, Santi PA, Wieslander J, Michael AF. Distribution of familial nephritis antigen in normal tissue and renal basement membranes of patients with homozygous and heterozygous Alport familial nephritis and goodpasture antigen to novel collagen chains and type IV collagen. Lab Invest 1989 ; 61 : 279-89.
9. Gubler MC, Heidet L, Antignac C. Alport's syndrome, thin basement membrane nephropathy, nail patella syndrome, and type III collagen glomerulopathy. In Heptinstall's Pathology of the Kidney, 5th ed. edited by JC Jennette, JL Olson, MM Schwartz and FG Silva. Philadelphia : Lippincott-Raven Publishers, 1998 ; 1207-30.
10. Kashtan CE, Kleppel MM, Gubler MC. Immunohistologic findings in Alport syndrome. In Tryggvason K,(ed). Molecular pathology and genetics of Alport syndrome. Contrib Nephrol. Basel: Karger, 1996 ; 117 : 142-53.
11. Ninomiya Y, Kagawa M, Iyama K, Naito I, Kishiro Y, Seyer JM, Sugimoto M, Oohashi T, Sado Y. Differential expression of two basement membrane collagen genes COL4A5 and COL4A6, demonstrated by immunofluorescence staining using peptide-specific monoclonal antibodies. J Cell Biol 1995 ; 130 : 1219-29.
12. Tryggvason K. Mutations in type IV collagen genes and Alport phenotypes. In: Tryggvason K (ed). Molecular pathology and genetics of Alport syndrome. Contrib Nephrol. Basel: Karger, 1996 ; 117 : 154-71.
13. Knebelman B, Breillat C, Forestier L, Arrondel C, Jacassier D, Giatras I, Drouot L, Deschênes G, Grünfeld JP, Broyer M, Gubler MC, Antignac C. Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome. Am J Hum Genet 1996 ; 59 : 1227-32.
14. Antignac C, Zhou J, Sanak M, Cochat P, Roussel B, Deschenes G, Gros F, Knebelmann B, Hors-Cayla MC, Tryggvason K. Alport syndrome and diffuse leiomyomatosis: Deletions in the 5′ end of the COL4A5 collagen gene. Kidney Int 1992 ; 42 : 1178-83.
15. Zhou J, Mochizuki T, Smeets H, Antignac C, Laurila P, De Paepe A, Tryggvason K, Reeders ST. Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors. Science 1993; 261 : 1167-9.
16. Heidet L, Dahan K, Zhou J, Xu Z, Cochat P, Gould JDM, Leppig KA, Proesmans W, Guyot C, Guillot M, Roussel B, Tryggvason K, Grünfeld JP, Gubler MC, Antignac C. Deletions of both alpha 5(IV) and alpha 6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumors. Hum Mol Genet 1995 ; 4 : 99-108.
17. Heidet L, Cohen-Sola L, Boye E, Thorner P, Kemper MJ, David A, Larget Piet L, Zhou J, Flinter F, Zhang X, Gubler MC, Antignac C. Novel COL4A5/ COL4A6 deletions and further characterization of the diffuse leiomyomatosis-Alport syndrome (DL.AS) locus define the DL critical region. Cytogenet Cell Genet 1997 ; 78 : 240-6.
18. Segal Y, Peissel B, Renieri A, De Marchi M, Ballabio A, Pei Y, Zhou J. LINE-1 elements at the sites of molecular rearrangements in Alport syndromediffuse leiomyomatosis. Am J Hum Genet 1999 ; 64 : 62-9.
19. Heidet L, Cai Y, Sado Y, Ninomiya Y, Thorner P, Guicharnau L, Boye E, Chauvet V, Solal LC, Beziau A, Garcia-Torres R, Antignac C, Gubler MC. Diffuse leiomyomatosis associated with X-linked Alport syndrome : Extracellular matrix study using immunohistochemistry and in situ hybridization. Lab Invest 1997 ; 76 : 233-43.
20. Heidet L, Boye E, Cai Y, Zhang X, Flejou JF, Fekete F, Ninomiya Y, Gubler MC, Antignac C. Somatic Deletion of the 5′ ends of both the COL4A5 and COL4A6 genes in sporadic leiomyoma of the esophagus. Am J Pathol 1998 ; 152 : 673-8.
21. Kashtan CE, Kim Y. Distribution of the alpha 1 and alpha 2 chains of collagen IV and of collagen V and VI in Alport Syndrome. Kidney Int 1992 ; 42 : 115-26.
22. Muda AO, Rahimi S, Renieri A, Rizzoni G, Massella L, Faraggiana T. Ultrastructural immunocytochemistry of collagenous and non-collagenous proteins in fast frozen, freeze substituted, and low temperature embedded renal tissue in Alport syndrome. J Pathol 1997 ; 182 : 465-74.
23. Antignac C, Knebelmann B, Drouot L, Gros F, Deschênes G, Hors-Cayla MC, Zhou J, Tryggvason K, Grünfeld JP, Broyer M, Gubler MC. Deletions in the COL4A5 collagen gene in X-linked Alport syndrome. Characterization of the pathological transcripts in nonrenal cells and correlation with disease expression. J Clin Invest 1994 ; 93 : 1195-207.
24. Naito I, Kawai S, Nomura S, Sado Y, Osawa G. Relationship between COL4A5 gene mutation and distribution of type IV collagen in male X-linked Alport Syndrome. Japanese Alport Network. Kidney Int 1996 ; 50 : 304-11.
25. Mazzucco G, Barsotti P, Muda AO, Fortunato M, Mihatsch M, Torri-Tarelli L, Renieri A, Faraggiana T, De Marchi M, Monga G. Ultrastructural and immunohistochemical findings in Alport's syndrome: A study of 108 patients from 97 Italian families with particular emphasis on COL4A5 gene mutation correlations. J Am Soc Nephrol 1998 ; 9 : 1023-31.